Wynmark

Wynmark was a specialized clinical trial service provider that focused on site-based patient recruitment and retention for the pharmaceutical and biotechnology industries. The company provided customized solutions to accelerate clinical trial enrollment by working directly with investigative sites to identify and enroll qualified participants. By offering on-site support and data-driven recruitment strategies, Wynmark helped sponsors meet their enrollment timelines and reduce the costs associated with drug development. Their services were designed to bridge the gap between clinical research sites and the patient populations needed for successful trials. In 2011, Wynmark was acquired by Acurian, a major player in the patient recruitment space, to enhance its site-level support capabilities.